Human medicines European public assessment report (EPAR): Clopidogrel Krka d.d. (previously Zopya), clopidogrel, Date of authorisation: 20/09/2009, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Clopidogrel TAD, clopidogrel, Date of authorisation: 23/09/2009, Revision: 17, Status: Authorised

EMEA-002876-PIP02-23

Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 11, Status: Authorised

EMEA-002689-PIP02-23

EMEA-003176-PIP02-22

European Shortages Monitoring Platform (ESMP) essentials: Industry and network reporting requirements

European Shortages Monitoring Platform (ESMP) Informational brief

Amended Biologics Working Party Vaccines Quality Operational Expert Group (BV-OEG) Influenza Meeting: EU recommendations for the seasonal influenza vaccine composition for the season 2025/2026

Human medicines European public assessment report (EPAR): Actelsar HCT, telmisartan,hydrochlorothiazide, Date of authorisation: 13/03/2013, Revision: 19, Status: Authorised